MedPath

Effect of Artronat on the Quality of Life of Patient With Osteoarthritis

Not Applicable
Completed
Conditions
Osteoarthritis
Registration Number
NCT01356199
Lead Sponsor
Lescuyer Laboratory
Brief Summary

The purpose of this study is to determine whether the nutritional supplement ARTRONAT improves the quality of life of patients with osteoarthritis.

Detailed Description

Osteoarthritis is a degenerative disease that greatly impairs the quality of life of patients. A nutritional supplement may help, in association with the normal treatment of osteoarthritis, improving the quality of life of such patients, in reducing pain and/or improving join flexibility.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
7
Inclusion Criteria
  • age 40-75 years
  • BMI 18.5-30
  • osteoarthritis type II or III
Exclusion Criteria
  • osteoarthritis type I or IV
  • allergy to one of the component of the supplement
  • blood pressure > 14/8
  • history of knee surgery

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Reduction of gonalgiaT8 months

measure with the WOMAC.

Secondary Outcome Measures
NameTimeMethod
Evaluation of the satisfactory relief of symptoms of osteoarthritis at each visit after the beginning of supplementation, assessed by the patients.T2, T4, T6, T8 months

Subjective global assessment measured on a 10-cm graduated scale (Visual Analogue Scale)

Trial Locations

Locations (1)

Centre Rééducation et Réadaptation Fonctionnelles de Trestel , Centre Hospitalier Pierre-Le-Damany Lannion

🇫🇷

Treviou Treguignec, France

Centre Rééducation et Réadaptation Fonctionnelles de Trestel , Centre Hospitalier Pierre-Le-Damany Lannion
🇫🇷Treviou Treguignec, France

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.